We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App





Zeesan Biotech Displays DNA Automated Extraction System

By LabMedica International staff writers
Posted on 05 Feb 2018
Zeesan Biotech (Fujian, China) displayed its DNA automated extraction system and real-time PCR kits for MDR/XDR-TB, HPV, HBB, etc. More...
at MEDLAB Middle East, the world’s largest attended laboratory and IVD exhibition and conference.
 
Zeesan is a biomedical company specializing in the development and production of molecular diagnostics related kits, instruments and reagents. The company’s product range includes the MeltPro series of molecular diagnostics products, automated DNA extraction machines and visible-light gel electrophoresis systems. At the MEDLAB Middle East 2018 held in Dubai, UAE, from February 5-8, 2018, Zeesan exhibited its Lab-Aid 824 nucleic acid extraction system, which enables automated, fast, reliable isolation and purification of high-quality nucleic acids for up to 24 samples per run. The entire extraction process is controlled by software and the system is intended for in vitro diagnostic use to provide high quality nucleic acid suitable for direct use in downstream application, such as amplification or other enzymatic reactions.
 
Visitors at Zeesan’s stand at the event also viewed the company’s wide range of real-time PCR kits for MDR/XDR-TB, HPV, HBB, etc. The company’s MeltPro High Risk HPV Genotyping Assay is a qualitative in vitro test kit used for HPV genotyping using cervical cells collected by swab, TCT or LCT. The test utilizes Polymerase Chain Reaction (PCR) for DNA amplification and nucleic acid hybridization for the detection of low-risk HPV types in one reaction. The MeltPro HBB test kit is meant for the detection of 12 gene mutations common in the Pakistani population, which are related to β –Thalassemia and is used for β-Thalassemia screening based on polymerase chain reaction and nucleic acid hybridization. 
 

New
Gold Member
Thyroid-Stimulating Hormone Test
ULTRA-TSH
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Calprotectin Test
CALiaGold
New
Glucose Tolerance Test
NERL Trutol
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The POC device rapidly predicts neonatal respiratory disease at birth in the NICU (Photo courtesy of SIME Diagnostics)

AI-Powered Lung Maturity Test Identifies Newborns at Higher Risk of Respiratory Distress

Each year, approximately 300,000 babies in the United States are born between 32 and 36 weeks' gestation, according to national health data. This group is at an elevated risk for respiratory distress,... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Pathology

view channel
Image: A biomarker discovery pipeline has shown promise as a noninvasive method of diagnosing CRC (Photo courtesy of NCI Center for Cancer Research)

Machine Learning Tool Enables Noninvasive Diagnosis and Monitoring of Colorectal Cancer

Colorectal cancer (CRC) is the second leading cause of cancer-related deaths in the United States when considering both genders. Colonoscopy remains the gold standard for CRC diagnosis, but it is invasive,... Read more

Technology

view channel
Image: Scanning electron microscopy images showing 3D micro-printed Limacon-shaped whispering-gallery-mode microcavities with different amounts of deformation (Photo courtesy of A. Ping Zhang/PolyU)

Tiny Microlaser Sensors with Supercharged Biosensing Ability to Enable Early Disease Diagnosis

Optical whispering-gallery-mode microlaser sensors function by trapping light within tiny microcavities. When target molecules bind to the cavity, they induce subtle changes in the laser’s frequency, allowing... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.